These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5115670)

  • 1. Correlated studies of a recombinant influenza-virus vaccine. II. Definition of antigenicity in experimental animals.
    Schulman JL; Kilbourne ED
    J Infect Dis; 1971 Nov; 124(5):463-72. PubMed ID: 5115670
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlated studies of a recombinant influenza-virus vaccine. 3. Protection against experimental influenza in man.
    Couch RB; Douglas RG; Fedson DS; Kasel JA
    J Infect Dis; 1971 Nov; 124(5):473-80. PubMed ID: 5000515
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlated studies of a recombinant influenza-virus vaccine. IV. Protection against naturally occurring influenza in military trainees.
    Leibovitz A; Coultrip RL; Kilbourne ED; Legters LJ; Smith CD; Chin J; Schulman JL
    J Infect Dis; 1971 Nov; 124(5):481-7. PubMed ID: 5115671
    [No Abstract]   [Full Text] [Related]  

  • 4. Related studies of a recombinant influenza-virus vaccine. I. Derivation and characterization of virus and vaccine.
    Kilbourne ED; Schulman JL; Schild GC; Schloer G; Swanson J; Bucher D
    J Infect Dis; 1971 Nov; 124(5):449-62. PubMed ID: 5115669
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of partial immunity to influenza by a neuraminidase-specific vaccine.
    Couch RB; Kasel JA; Gerin JL; Schulman JL; Kilbourne ED
    J Infect Dis; 1974 Apr; 129(4):411-20. PubMed ID: 4593871
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody response in man to influenza virus neuraminidase following influenza.
    Kilbourne ED; Christenson WN; Sande M
    J Virol; 1968 Jul; 2(7):761-2. PubMed ID: 5723531
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of antibodies to neuraminidase of A2-Hong Kong and A2-Taiwan influenza viruses after administration of different Hong Kong vaccines and after natural infection in humans.
    Závadová H
    Acta Virol; 1973 Jul; 17(4):287-92. PubMed ID: 4148207
    [No Abstract]   [Full Text] [Related]  

  • 8. Antigenicity of influenza vaccine from bovine cell cultures.
    Leiderman E; Mogabgab WJ
    Appl Microbiol; 1969 Oct; 18(4):596-600. PubMed ID: 4905036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-neuraminidase antibody response in serum and nasal secretions following intranasal or subcutaneous inactivated A2-Hong Kong-68 influenza virus vaccine.
    Fedson DS; Fulk RV; Huber MA; Reisberg MA; Kasel JA
    J Immunol; 1971 Sep; 107(3):730-7. PubMed ID: 4999093
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody response to influenza virus enzyme in man.
    Davenport FM; Minuse E; Hennessy AV
    Arch Environ Health; 1970 Sep; 21(3):307-11. PubMed ID: 5504431
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental studies on influenza A2 virus infection after peroral inoculation.
    Sidorova LA; Alekseyeva AK
    Acta Virol; 1973 Jul; 17(4):293-7. PubMed ID: 4148208
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunogenicity of 1967 polyvalent and 1968 Hong Kong influenza vaccines.
    Mogabgab WJ; Leiderman E
    JAMA; 1970 Mar; 211(10):1672-6. PubMed ID: 4984268
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of subcutaneous, nasal, and combined influenza vaccination. I. Antigenicity.
    Gwaltney JM; Edmondson WP; Rothenberg R; White PW
    Am J Epidemiol; 1971 Jun; 93(6):472-9. PubMed ID: 5562719
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of antineuraminidase antibody in immunity to influenza virus infection.
    Schulman JL
    Bull World Health Organ; 1969; 41(3):647-50. PubMed ID: 5309490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Viremia in influenza A2 (Hong Kong)].
    Poliakova TG; Ketiladze ES; Zhilina NN; Stakhanova VM
    Vopr Virusol; 1970; 15(6):724-8. PubMed ID: 4932343
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiviral activity of antiserum specific for an influenza virus neuraminidase.
    Kilbourne ED; Laver WG; Schulman JL; Webster RG
    J Virol; 1968 Apr; 2(4):281-8. PubMed ID: 4911843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of recombination in the production of influenza vaccine strains.
    McCahon D; Beare AS; Schild GC; Hall TS
    Postgrad Med J; 1973 Mar; 49(569):195-9. PubMed ID: 4802647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental sequence and intracellular sites of synthesis of three structural protein antigens of influenza A2 virus.
    Maeno K; Kilbourne ED
    J Virol; 1970 Feb; 5(2):153-64. PubMed ID: 4914627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of immunity on transmission of influenza: experimental studies.
    Schulman JL
    Prog Med Virol; 1970; 12():128-60. PubMed ID: 4921481
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of a live, attenuated recombinant influenza vaccine in high school children.
    Schiff GM; Linnemann CC; shea L; Lange B; Rotte T
    Infect Immun; 1975 Apr; 11(4):754-7. PubMed ID: 1168170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.